Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00230685
Status:
RECRUITING
Last Update Posted:
2023-09-28
First Post:
2005-09-29
Brief Title:
Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia
Sponsor:
Imperial College London
Organization:
Imperial College London
Study Overview
Official Title:
Hammersmith Hospital Patients With Pulmonary Arteriovenous Malformations PAVMs and Hereditary Haemorrhagic Telangiectasia
Status:
RECRUITING
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This observational study is for individuals with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that are reviewed at the Hammersmith Hospital London
Detailed Description:
The Hammersmith Hospital provides a clinical service for patients with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that is unique in the United Kingdom Measurements obtained as part of standard clinical practice that has evolved since 1985 allow us to assess whether particular groups of individuals that we see are more prone to recognised complications such as strokes brain abscesses pregnancy related complications or pulmonary hypertension We hypothesise that certain clinical characteristics will predict the susceptibility of individuals to particular complications
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None